Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07275138

Acute Cardiovascular and Neuromuscular Responses to Walking With Blood Flow Restriction (BFR) in Older Adults

The goal of this clinical trial is to explore how walking combined with different levels of partial blood flow restriction (BFR) affects cardiovascular, neuromuscular, and movement (kinematic) variables in older adults.

The main questions it aims to answer are:

Does walking with BFR increase internal effort, as shown by cardiovascular changes, and is this effect proportional to the level of restriction?

Does walking with BFR temporarily reduce neuromuscular control, and is this reduction greater at higher restriction levels?

Does walking with BFR change gait movement patterns?

This study uses a crossover design, meaning that each participant will complete all four conditions and serve as their own control.

Participants will:

Take part in walking sessions under four conditions with different levels of restriction: BFR40%, BFR80%, SHAM (0% BFR), and CON (without BFR).

Have their cardiovascular responses, muscle performance, and gait movement patterns measured.

Report their perceptions of the sessions, including Rate of Perceived Exertion (RPE), satisfaction, and possible side effects.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

60 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Sport of University of Porto, Porto, Porto District, Portugal

Loading trial locations.

About this study

This innovative research project aims to explore the effect of the novel BFR technique, combined with walking, as a non-pharmacological strategy to prevent or reverse sarcopenia and thereby improve the quality of life in sedentary older adults. BFR involves the use of a specialized pneumatic cuff to restrict venous blood flow to a muscle while partially inhibiting arterial flow, and it can be applied either at rest or in combination with exercise.

The application of BFR combined with exercise has shown promise as a tool to induce favorable physiological effects at lower training doses, that is, at lower intensities (e.g., lower intensities or slower walking or running speeds), compared to active control groups. However, despite the promising benefits reported in some studies, comprehensive investigation of the cardiovascular and neuromuscular responses during BFR combined with walking remains a largely unexplored area, both in healthy participants and special populations. This knowledge gap is particularly relevant when considering the substantial benefits that older adults and individuals with mobility limitations could gain from BFR combined with walking, especially given their potential difficulty in adhering to the minimum exercise dosage requirements recommended by the World Health Organization

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged between 60 and 90 years.

Exclusion criteria

  • Being institutionalized.
  • Peripheral vascular disease, defined by an ankle-brachial index (ABI) outside the normal range (0.9-1.4).
  • Uncontrolled arterial hypertension (>180/110 mmHg).
  • Any contraindication to exercise, based on self-reported medical history and PAR-Q+.

Treatment and study plan

Walking

Behavioral

Participants will perform two continuous 10-minute walking bouts, separated by a 3-minute seated recovery period to allow reperfusion following BFR or pause, along a rectangular 40-meter walking circuit (15×5 m). Walking cadence will be standardized at 112 steps per minute.

Other names: Physical activity, Aerobic exercise, Cardio exercise, Endurance exercise, Functional movement

Primary outcomes

  1. Blood pressure

    Time frame: 25 minutes

    Systolic, diastolic and mean blood pressure will be obtained by a photoplethysmography sensor. Units: mmHg

  2. Heart rate

    Time frame: 60 minutes

    The average and maximum values will be obtained using a chest-worn heart rate sensor. Unit: beats per minute (bpm)

  3. RR-Interval Time-Domain Metrics

    Time frame: 60 minutes

    Standard time-domain HRV metrics-including mean RR intervals (meanRR), the standard deviation of normal-to-normal intervals (SDNN), and the root mean square of successive differences (RMSSD)-will be derived from inter-beat interval data exported from a chest-worn heart rate sensor (epochs of 5 min).

    Units: milliseconds (ms).

  4. RR-Interval Nonlinear Metric

    Time frame: 60 minutes

    Short-term fractal scaling (DFA α1) will be calculated from inter-beat interval data exported from a chest-worn heart rate sensor (epochs of 5 min).

    Units: dimensionless.

  5. Maximum isometric strength

    Time frame: 10 minutes

    Maximum voluntary isometric contraction (MVIC) force during a knee-extension task will be recorded using a force-gauge device.

    Unit: Newtons (N)

  6. Force steadiness

    Time frame: 10 minutes

    Force steadiness will be evaluated from the RMSSD of the coefficient of variation (CV) during a 30-s submaximal isometric knee-extension contraction at 30% MVIC, using a force-gauge device with data-analysis software.

    Unit: Percentage (%)

Secondary outcomes

  1. Arterial stiffness

    Time frame: 25 minutes

    It will be assessed by finger-toe pulse wave velocity (PWV) method. Units: m/s

  2. Temporal Gait Parameters

    Time frame: 20 minutes

    Mean temporal gait parameters-including stride time, step time, and stance time-will be derived from IMU-based measurements.

    Units: milliseconds (ms).

  3. Temporal Gait Variability

    Time frame: 20 minutes

    Stride-to-stride temporal variability (stride time, step time, stance time) will be computed from walking recordings collected using a wearable inertial measurement unit (IMU) equipped with a triaxial accelerometer and gyroscope. Variability will be expressed as the coefficient of variation (CV) for each temporal metric.

    Units: Percentage (%)

  4. Postural Stability

    Time frame: 10 minutes

    Postural stability in mediolateral (ML) and anterior-posterior (AP) directions will be assessed during quiet standing under four conditions (eyes open/closed × firm/foam surface). A wearable IMU will record triaxial centre-of-mass acceleration. Stability metrics will be computed as -ln[m/s²], where higher values reflect lower acceleration and therefore better postural control.

    Units: -ln[m/s²]

  5. Internal subjective load

    Time frame: 20 minutes

    Perceived exertion during walking will be quantified every 5 minutes using the OMNI-RES scale.

    Units: Points (0-10).

  6. Adverse effects

    Time frame: 20 minutes

    Severity of adverse sensations (e.g., tingling, burning, numbness, fatigue, discomfort, petechiae) potentially associated with BFR will be recorded.

    Units: Points (0-5).

  7. Affective Responses

    Time frame: 20 minutes

    Affective valence during the exercise bout will be assessed using the Visual Analogue Feeling Scale.

    Units: Points (-5 to +5).

Study contacts

Contact information is provided by the study sponsor or research team.

Marta Sevilla-Sanchez, Postdoctoral research

CONTACT

[email protected]

34 637 235 257

Sponsors and collaborators

Lead sponsor

Universidade da Coruña

Other

Collaborators

  • Ministry of Work and Welfare - Xunta de Galicia
  • Universidade do Porto
  • University of La Laguna

Registry information

Official study title

Acute Cardiovascular and Neuromuscular Responses to Walking With Blood Flow Restriction in Older Adults: a Study Protocol for a Randomized Crossover Trial

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 10, 2025
Registry last updated
Dec 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.